Non-Invasive Prenatal Testing (NIPT) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Pages: 57 Published: July 29, 2022 Report Code: GDME1408EPD

Non-invasive prenatal screening is a method that determines the risk of genetic abnormalities in the fetus by analyzing the cfDNA. GlobalData's Medical Devices sector report, “Non-invasive prenatal testing (NIPT) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Non-invasive prenatal testing (NIPT) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Non-invasive prenatal testing (NIPT) report provides key information and data related to:

Extensive coverage of the Non-invasive prenatal testing (NIPT) under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and the number of trials of the major Non-invasive prenatal testing (NIPT) pipeline products.

Review of Recent Developments in the segment / industry

The Non-invasive prenatal testing (NIPT) report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

Identify and understand important and diverse types of Non-invasive prenatal testing (NIPT) under development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025

• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports

• 64,000+ medical equipment company profiles

• 5,600+ company profiles of medical equipment manufacturers in China and India

• 2,200+ company profiles of medical equipment manufacturers in Japan

• 1,200+ companies’ revenue splits and market shares

• 1,600+ quarterly and annual medical equipment company financials

• 850+ medical equipment company SWOTs

• 28,000+ pipeline product profiles

• 56,400+ marketed product profiles

• 47,000+ clinical trials

• 41,500+ trial investigators

• 7,000+ reports on companies with products in development

• 44,000+ deals in the medical equipment industry

• 1,100+ surgical and diagnostic procedures by therapy area

• 50+ key healthcare indicators by country

• 431,000+ Themes Content Items

• 600+ Influencers

• 1,900+ Analysts & Researchers

• 0.5m+ Community Members

• 141,000+ Macroeconomic Indicators

• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:

https://medical.globaldata.com/home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

– Extensive coverage of the Non-invasive prenatal testing (NIPT) under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Non-invasive prenatal testing (NIPT) and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

– Identify and understand important and diverse types of Non-invasive prenatal testing (NIPT) under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Key Players

Agena Bioscience Inc

Amity University

BCML GmbH

BioCeps (Inactive)

Biocept Inc

Biofidelity Ltd

BioFluidica Microtechnologies LLC

Cardiff Oncology Inc

Celula Inc

ChromaCode Inc

Echelon Diagnostics Inc

Elysium Health Inc

Fluxion Biosciences Inc

Helicos BioSciences Corporation

Illumina Inc

INEX Innovate Pte Ltd

Johns Hopkins University

Juno Diagnostics Inc

KellBenx Inc (Inactive)

Laval University

Maastricht University Medical Center

Natera Inc

Oxford Gene Technology Ltd

PerkinElmer Inc

Sequenom Inc

Standard BioTools Inc

StellarGene Technologies Pvt Ltd

The Chaim Sheba Medical Center

The Chinese University of Hong Kong

thromboDx BV

Tufts Medical Center

University of Oxford

Table of Contents

1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 8

2 Introduction 9

2.1 Non-invasive prenatal testing (NIPT) Overview 9

3 Products under Development 10

3.1 Non-invasive prenatal testing (NIPT) – Pipeline Products by Stage of Development 10

3.2 Non-invasive prenatal testing (NIPT) – Pipeline Products by Territory 11

3.3 Non-invasive prenatal testing (NIPT) – Pipeline Products by Regulatory Path 12

3.4 Non-invasive prenatal testing (NIPT) – Pipeline Products by Estimated Approval Date 13

3.5 Non-invasive prenatal testing (NIPT) – Ongoing Clinical Trials 14

4 Non-invasive prenatal testing (NIPT) – Pipeline Products under Development by Companies 15

4.1 Non-invasive prenatal testing (NIPT) Companies – Pipeline Products by Stage of Development 15

4.2 Non-invasive prenatal testing (NIPT) – Pipeline Products by Stage of Development 17

5 Non-invasive prenatal testing (NIPT) Companies and Product Overview 18

5.1 Agena Bioscience Inc Company Overview 18

5.1.1 Agena Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 18

5.2 Amity University Company Overview 19

5.2.1 Amity University Pipeline Products & Ongoing Clinical Trials Overview 19

5.3 BCML GmbH Company Overview 20

5.3.1 BCML GmbH Pipeline Products & Ongoing Clinical Trials Overview 20

5.4 BioCeps (Inactive) Company Overview 21

5.4.1 BioCeps (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 21

5.5 Biocept Inc Company Overview 22

5.5.1 Biocept Inc Pipeline Products & Ongoing Clinical Trials Overview 22

5.6 Biofidelity Ltd Company Overview 23

5.6.1 Biofidelity Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

5.7 BioFluidica Microtechnologies LLC Company Overview 24

5.7.1 BioFluidica Microtechnologies LLC Pipeline Products & Ongoing Clinical Trials Overview 24

5.8 Cardiff Oncology Inc Company Overview 25

5.8.1 Cardiff Oncology Inc Pipeline Products & Ongoing Clinical Trials Overview 25

5.9 Celula Inc Company Overview 26

5.9.1 Celula Inc Pipeline Products & Ongoing Clinical Trials Overview 26

5.10 ChromaCode Inc Company Overview 27

5.10.1 ChromaCode Inc Pipeline Products & Ongoing Clinical Trials Overview 27

5.11 Echelon Diagnostics Inc Company Overview 28

5.11.1 Echelon Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 28

5.12 Elysium Health Inc Company Overview 29

5.12.1 Elysium Health Inc Pipeline Products & Ongoing Clinical Trials Overview 29

5.13 Fluxion Biosciences Inc Company Overview 30

5.13.1 Fluxion Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 30

5.14 Helicos BioSciences Corporation Company Overview 31

5.14.1 Helicos BioSciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 31

5.15 Illumina Inc Company Overview 32

5.15.1 Illumina Inc Pipeline Products & Ongoing Clinical Trials Overview 32

5.16 INEX Innovate Pte Ltd Company Overview 33

5.16.1 INEX Innovate Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 33

5.17 Johns Hopkins University Company Overview 34

5.17.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 34

5.18 Juno Diagnostics Inc Company Overview 35

5.18.1 Juno Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 35

5.19 KellBenx Inc (Inactive) Company Overview 36

5.19.1 KellBenx Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 36

5.20 Laval University Company Overview 37

5.20.1 Laval University Pipeline Products & Ongoing Clinical Trials Overview 37

5.21 Maastricht University Medical Center Company Overview 40

5.21.1 Maastricht University Medical Center Pipeline Products & Ongoing Clinical Trials Overview 40

5.22 Natera Inc Company Overview 41

5.22.1 Natera Inc Pipeline Products & Ongoing Clinical Trials Overview 41

5.23 Oxford Gene Technology Ltd Company Overview 42

5.23.1 Oxford Gene Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 42

5.24 PerkinElmer Inc Company Overview 43

5.24.1 PerkinElmer Inc Pipeline Products & Ongoing Clinical Trials Overview 43

5.25 Sequenom Inc Company Overview 44

5.25.1 Sequenom Inc Pipeline Products & Ongoing Clinical Trials Overview 44

5.26 Standard BioTools Inc Company Overview 45

5.26.1 Standard BioTools Inc Pipeline Products & Ongoing Clinical Trials Overview 45

5.27 StellarGene Technologies Pvt Ltd Company Overview 46

5.27.1 StellarGene Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 46

5.28 The Chaim Sheba Medical Center Company Overview 47

5.28.1 The Chaim Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview 47

5.29 The Chinese University of Hong Kong Company Overview 48

5.29.1 The Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 48

5.30 thromboDx BV Company Overview 51

5.30.1 thromboDx BV Pipeline Products & Ongoing Clinical Trials Overview 51

5.31 Tufts Medical Center Company Overview 52

5.31.1 Tufts Medical Center Pipeline Products & Ongoing Clinical Trials Overview 52

5.32 University of Oxford Company Overview 53

5.32.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 53

6 Appendix 54

6.1 Methodology 54

6.2 About GlobalData 57

6.3 Contact Us 57

6.4 Disclaimer 57

List of Tables

Non-invasive prenatal testing (NIPT) – Pipeline Products by Stage of Development 10

Non-invasive prenatal testing (NIPT) – Pipeline Products by Territory 11

Non-invasive prenatal testing (NIPT) – Pipeline Products by Regulatory Path 12

Non-invasive prenatal testing (NIPT) – Pipeline Products by Estimated Approval Date 13

Non-invasive prenatal testing (NIPT) – Ongoing Clinical Trials 14

Non-invasive prenatal testing (NIPT) Companies – Pipeline Products by Stage of Development 15

Non-invasive prenatal testing (NIPT) – Pipeline Products by Stage of Development 17

Agena Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 18

Sensigene Trisomy 21 Laboratory Developed Test – Product Status 18

Sensigene Trisomy 21 Laboratory Developed Test – Product Description 18

Amity University Pipeline Products & Ongoing Clinical Trials Overview 19

Prenatal Screening Kit – Product Status 19

Prenatal Screening Kit – Product Description 19

BCML GmbH Pipeline Products & Ongoing Clinical Trials Overview 20

Prenatal Diagnosis Biochip – Product Status 20

Prenatal Diagnosis Biochip – Product Description 20

BioCeps (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 21

Prenatal Diagnostic Test – Product Status 21

Prenatal Diagnostic Test – Product Description 21

Biocept Inc Pipeline Products & Ongoing Clinical Trials Overview 22

preCEED – Product Status 22

preCEED – Product Description 22

Biofidelity Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

Molecular Diagnostic Assay – Pre-natal Testing Panel – Product Status 23

Molecular Diagnostic Assay – Pre-natal Testing Panel – Product Description 23

BioFluidica Microtechnologies LLC Pipeline Products & Ongoing Clinical Trials Overview 24

Non-Invasive Prenatal Test – Product Status 24

Non-Invasive Prenatal Test – Product Description 24

Cardiff Oncology Inc Pipeline Products & Ongoing Clinical Trials Overview 25

Non Invasive Prenatal Screening Test – Product Status 25

Non Invasive Prenatal Screening Test – Product Description 25

Celula Inc Pipeline Products & Ongoing Clinical Trials Overview 26

Non-Invasive Pre-Natal Test – Product Status 26

Non-Invasive Pre-Natal Test – Product Description 26

ChromaCode Inc Pipeline Products & Ongoing Clinical Trials Overview 27

HDPCR Non-Invasive Prenatal Testing (NIPT) Panel – Product Status 27

HDPCR Non-Invasive Prenatal Testing (NIPT) Panel – Product Description 27

Echelon Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 28

PrenatalDx – Product Status 28

PrenatalDx – Product Description 28

Elysium Health Inc Pipeline Products & Ongoing Clinical Trials Overview 29

Non-Invasive Test – Neurodevelopmental Delay – Product Status 29

Non-Invasive Test – Neurodevelopmental Delay – Product Description 29

Fluxion Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 30

Spotlight NIPT – Product Status 30

Spotlight NIPT – Product Description 30

Helicos BioSciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 31

Prenatal Diagnostic Test – Product Status 31

Prenatal Diagnostic Test – Product Description 31

Illumina Inc Pipeline Products & Ongoing Clinical Trials Overview 32

Verifi Prenatal Test – Product Status 32

Verifi Prenatal Test – Product Description 32

INEX Innovate Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 33

Lexi – Product Status 33

Lexi – Product Description 33

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 34

Prenatal Diagnostic Test – Product Status 34

Prenatal Diagnostic Test – Product Description 34

Juno Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 35

Noninvasive Prenatal Test – Product Status 35

Noninvasive Prenatal Test – Product Description 35

KellBenx Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 36

KellBenx Prenatal Diagnostic Test – Product Status 36

KellBenx Prenatal Diagnostic Test – Product Description 36

Laval University Pipeline Products & Ongoing Clinical Trials Overview 37

Trisomy 21 Blood Test – Product Status 37

Trisomy 21 Blood Test – Product Description 37

Laval University – Ongoing Clinical Trials Overview 38

Trisomy 21 Blood Test – Personalized Genomics for Prenatal Abnormalities Screening Using Maternal Blood : Towards First Tier Screening and Beyond 39

Maastricht University Medical Center Pipeline Products & Ongoing Clinical Trials Overview 40

MLPA Test – Product Status 40

MLPA Test – Product Description 40

Natera Inc Pipeline Products & Ongoing Clinical Trials Overview 41

Panorama Non-Invasive Prenatal Expanded Test – Product Status 41

Panorama Non-Invasive Prenatal Expanded Test – Product Description 41

Oxford Gene Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 42

Non-Invasive Prenatal Test – Down's Syndrome – Product Status 42

Non-Invasive Prenatal Test – Down's Syndrome – Product Description 42

PerkinElmer Inc Pipeline Products & Ongoing Clinical Trials Overview 43

Diagnostic Test – Preterm Birth – Product Status 43

Diagnostic Test – Preterm Birth – Product Description 43

Sequenom Inc Pipeline Products & Ongoing Clinical Trials Overview 44

Next Generation Noninvasive Prenatal Test (NIPT) – Product Status 44

Next Generation Noninvasive Prenatal Test (NIPT) – Product Description 44

Standard BioTools Inc Pipeline Products & Ongoing Clinical Trials Overview 45

Non-Invasive Prenatal Diagnostic Test – Fetal Aneuploidies – Product Status 45

Non-Invasive Prenatal Diagnostic Test – Fetal Aneuploidies – Product Description 45

StellarGene Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 46

Non-Invasive Prenatal Test – Product Status 46

Non-Invasive Prenatal Test – Product Description 46

The Chaim Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview 47

Non-Invasive Prenatal Diagnostic Assay – Product Status 47

Non-Invasive Prenatal Diagnostic Assay – Product Description 47

The Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 48

Biomarker Assay – Prenatal Diagnosis – Product Status 48

Biomarker Assay – Prenatal Diagnosis – Product Description 48

Biomarker Test – Early Human Birth – Product Status 49

Biomarker Test – Early Human Birth – Product Description 49

mRNA based Prenatal Diagnostic Kit – Product Status 49

mRNA based Prenatal Diagnostic Kit – Product Description 50

thromboDx BV Pipeline Products & Ongoing Clinical Trials Overview 51

Prenatal Screening Test – Product Status 51

Prenatal Screening Test – Product Description 51

Tufts Medical Center Pipeline Products & Ongoing Clinical Trials Overview 52

NPY2R Saliva Test – Product Status 52

NPY2R Saliva Test – Product Description 52

University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 53

Prenatal Diagnostic Test – Sickle-Cell Disease – Product Status 53

Prenatal Diagnostic Test – Sickle-Cell Disease – Product Description 53

Glossary 56

List of Figures

Non-invasive prenatal testing (NIPT) – Pipeline Products by Stage of Development 10

Non-invasive prenatal testing (NIPT) – Pipeline Products by Territory 11

Non-invasive prenatal testing (NIPT) – Pipeline Products by Regulatory Path 12

Non-invasive prenatal testing (NIPT) – Pipeline Products by Estimated Approval Date 13

Non-invasive prenatal testing (NIPT) – Ongoing Clinical Trials 14

Frequently Asked Questions

Request a Free Sample
$4000

Can be used by individual purchaser only

$12000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.